Cheryl Gault

Direttore operativo presso Rapport Therapeutics, Inc.

44 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Abraham Ceesay	M	46	IRONWOOD PHARMACEUTICALS, INC. Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	6 anni
Julie McHugh	F	59	IRONWOOD PHARMACEUTICALS, INC.	10 anni
David Bredt	M	-	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	2 anni
Mark Currie	M	69	IRONWOOD PHARMACEUTICALS, INC.	22 anni
Steve Paul	M	-	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	2 anni
Ronald Silver	M	42	IRONWOOD PHARMACEUTICALS, INC.	6 anni
Andrew Dreyfus	M	65	IRONWOOD PHARMACEUTICALS, INC.	8 anni
Catherine Moukheibir	F	64	IRONWOOD PHARMACEUTICALS, INC.	5 anni
Marcel Moulaison	M	-	IRONWOOD PHARMACEUTICALS, INC.	10 anni
Jon Duane	M	65	IRONWOOD PHARMACEUTICALS, INC.	5 anni
Marla Kessler	F	54	IRONWOOD PHARMACEUTICALS, INC.	5 anni
Mike Nanfito	M	-	IRONWOOD PHARMACEUTICALS, INC.	12 anni
Greg Martini	M	-	IRONWOOD PHARMACEUTICALS, INC.	7 anni
Raymond Kelleher	M	59	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	1 anni
James Healy	M	59	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	1 anni
Terry-Ann Burrell	F	47	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	-
Reid Huber	M	52	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	2 anni
Beth Calitri	F	-	IRONWOOD PHARMACEUTICALS, INC.	5 anni
Troy Ignelzi	M	56	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	1 anni
Jeffrey Tong	M	48	Rapport Therapeutics, Inc. Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.	-
Michael Shetzline	M	65	IRONWOOD PHARMACEUTICALS, INC.	5 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Joe C. Cook	M	82	IRONWOOD PHARMACEUTICALS, INC.	17 anni
Gina Consylman	F	52	IRONWOOD PHARMACEUTICALS, INC.	7 anni
Jason Rickard	M	53	IRONWOOD PHARMACEUTICALS, INC.	11 anni
James M. DeTore	M	59	IRONWOOD PHARMACEUTICALS, INC.	11 anni
Brian M. Cali	M	-	IRONWOOD PHARMACEUTICALS, INC.	21 anni
Terry McGuire	M	68	IRONWOOD PHARMACEUTICALS, INC.	21 anni
Peter Hecht	M	60	IRONWOOD PHARMACEUTICALS, INC.	21 anni
Bryan Roberts	M	57	IRONWOOD PHARMACEUTICALS, INC.	15 anni
Amy Schulman	F	63	IRONWOOD PHARMACEUTICALS, INC.	2 anni
Kelly MacDonald	F	40	IRONWOOD PHARMACEUTICALS, INC.	8 anni
Marsha Fanucci	F	70	IRONWOOD PHARMACEUTICALS, INC.	10 anni
Lawrence Olanoff	M	72	IRONWOOD PHARMACEUTICALS, INC.	7 anni
Edward Owens	M	77	IRONWOOD PHARMACEUTICALS, INC.	9 anni
Gina Bornino Miller	F	63	IRONWOOD PHARMACEUTICALS, INC.	13 anni
Douglas Williams	M	66	IRONWOOD PHARMACEUTICALS, INC.	5 anni
David Ebersman	M	54	IRONWOOD PHARMACEUTICALS, INC.	6 anni
Mark Mallon	M	61	IRONWOOD PHARMACEUTICALS, INC.	2 anni
Michael Higgins	M	61	IRONWOOD PHARMACEUTICALS, INC.	11 anni
David Evans Shaw	M	71	IRONWOOD PHARMACEUTICALS, INC.	10 anni
George Conrades	M	85	IRONWOOD PHARMACEUTICALS, INC.	11 anni
Mark Ragosa	M	50	IRONWOOD PHARMACEUTICALS, INC.	2 anni
Christopher T. Walsh	M	80	IRONWOOD PHARMACEUTICALS, INC.	14 anni
Christina Isacson	F	45	IRONWOOD PHARMACEUTICALS, INC.	6 anni
Xiao Bing Li	M	56	IRONWOOD PHARMACEUTICALS, INC.	2 anni
Michelle Robertson	F	57	IRONWOOD PHARMACEUTICALS, INC.	3 anni
Lisa Fiering	F	-	IRONWOOD PHARMACEUTICALS, INC.	3 anni
Rhonda Chicko	F	58	IRONWOOD PHARMACEUTICALS, INC.	10 anni
William I. Huyett	M	68	IRONWOOD PHARMACEUTICALS, INC.	2 anni
Jonathan Rosin	M	-	IRONWOOD PHARMACEUTICALS, INC.	7 anni
Thomas Graney	M	60	IRONWOOD PHARMACEUTICALS, INC.	3 anni
John Crowley	M	51	IRONWOOD PHARMACEUTICALS, INC.	1 anni
Christopher Wright	M	58	IRONWOOD PHARMACEUTICALS, INC.	-
Michael Mendelsohn	M	69	IRONWOOD PHARMACEUTICALS, INC.	4 anni
Michael L. Hall	M	62	IRONWOOD PHARMACEUTICALS, INC.	-
Lisa Adler	F	-	IRONWOOD PHARMACEUTICALS, INC.	-
Jeffrey M. Johnston	M	-	IRONWOOD PHARMACEUTICALS, INC.	11 anni
Robert Lippe	M	59	IRONWOOD PHARMACEUTICALS, INC.	3 anni
Mark D. Plinio	M	57	IRONWOOD PHARMACEUTICALS, INC.	4 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	59	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni